Literature DB >> 20534695

Neural crest-specific loss of Prkar1a causes perinatal lethality resulting from defects in intramembranous ossification.

Georgette N Jones1, Daphne R Pringle, Zhirong Yin, Michelle M Carlton, Kimerly A Powell, Michael B Weinstein, Ramiro E Toribio, Krista M D La Perle, Lawrence S Kirschner.   

Abstract

The cranial neural crest (CNC) undergoes complex molecular and morphological changes during embryogenesis in order to form the vertebrate skull, and nearly three quarters of all birth defects result from defects in craniofacial development. The molecular events leading to CNC differentiation have been extensively studied; however, the role of the cAMP-dependent protein kinase [protein kinase A (PKA)] during craniofacial development has only been described in palate formation. Here, we provide evidence that strict PKA regulation in postmigratory CNC cells is essential during craniofacial bone development. Selective inactivation of Prkar1a, a regulatory subunit of the PKA holoenzyme, in the CNC results in perinatal lethality caused by dysmorphic craniofacial development and subsequent asphyxiation. Additionally, aberrant differentiation of CNC mesenchymal cells results in anomalous intramembranous ossification characterized by formation of cartilaginous islands in some areas and osteolysis of bony trabeculae with fibrous connective tissue stabilization in others. Genetic interaction studies revealed that genetic reduction of the PKA catalytic subunit C(alpha) was able to rescue the phenotype, whereas reduction in Cbeta had no effect. Overall, these observations provide evidence of the essential role of proper regulation of PKA during the ossification of the bones of the skull. This knowledge may have implications for the understanding and treatment of craniofacial birth defects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534695      PMCID: PMC2940464          DOI: 10.1210/me.2009-0439

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  29 in total

1.  Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins.

Authors:  Kiran S Nadella; Lawrence S Kirschner
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

2.  TGF-beta signaling in murine embryonic palate cells involves phosphorylation of the CREB transcription factor.

Authors:  M B Potchinsky; W M Weston; M R Lloyd; R M Greene
Journal:  Exp Cell Res       Date:  1997-02-25       Impact factor: 3.905

3.  A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.

Authors:  Lawrence S Kirschner; Donna F Kusewitt; Ludmila Matyakhina; William H Towns; J Aidan Carney; Heiner Westphal; Constantine A Stratakis
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

4.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

5.  Epigenetic control of skull morphogenesis by histone deacetylase 8.

Authors:  Michael Haberland; Mayssa H Mokalled; Rusty L Montgomery; Eric N Olson
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

6.  Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase.

Authors:  M Qi; M Zhuo; B S Skålhegg; E P Brandon; E R Kandel; G S McKnight; R L Idzerda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 7.  Mouse models of altered protein kinase A signaling.

Authors:  Lawrence S Kirschner; Zhirong Yin; Georgette N Jones; Emilia Mahoney
Journal:  Endocr Relat Cancer       Date:  2009-05-26       Impact factor: 5.678

8.  Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis.

Authors:  Zhirong Yin; Georgette N Jones; William H Towns; Xiaoli Zhang; E Dale Abel; Philip F Binkley; David Jarjoura; Lawrence S Kirschner
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

9.  Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A.

Authors:  Emilia Pavel; Kiran Nadella; William H Towns; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2007-10-11

10.  Development of craniofacial structures in transgenic mice with constitutively active PTH/PTHrP receptor.

Authors:  T W Tsutsui; M Riminucci; Kenn Holmbeck; P Bianco; P G Robey
Journal:  Bone       Date:  2007-10-16       Impact factor: 4.398

View more
  11 in total

Review 1.  3-dimensional imaging modalities for phenotyping genetically engineered mice.

Authors:  K A Powell; D Wilson
Journal:  Vet Pathol       Date:  2011-12-06       Impact factor: 2.221

2.  Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors.

Authors:  Sílvia F Sousa; Ricardo S Gomez; Marina G Diniz; Vanessa F Bernardes; Flávia F C Soares; João Artur R Brito; Sophie Liu; Hélder Antônio R Pontes; Constantine A Stratakis; Carolina C Gomes
Journal:  Endocr Relat Cancer       Date:  2015-04-13       Impact factor: 5.678

3.  Knockdown of PRKAR1A, the gene responsible for Carney complex, interferes with differentiation in osteoblastic cells.

Authors:  Mei Zhang; Parmeet K Manchanda; Dayong Wu; Qianben Wang; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2014-02-07

4.  Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells.

Authors:  Ni Qiu; Honghao Zhou; Zhousheng Xiao
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

5.  Differential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a.

Authors:  Zhirong Yin; Daphne R Pringle; Georgette N Jones; Kimberly M Kelly; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2011-08-18

6.  Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.

Authors:  Daphne R Pringle; Zhirong Yin; Audrey A Lee; Parmeet K Manchanda; Lianbo Yu; Alfred F Parlow; David Jarjoura; Krista M D La Perle; Lawrence S Kirschner
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

Review 7.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

8.  Nasal septum morphology in human fetuses in computed tomography images.

Authors:  Iwona Teul; G Slawinski; J Lewandowski; E Dzieciolowska-Baran; A Gawlikowska-Sroka; F Czerwinski
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

9.  Integrated analysis identifying long non-coding RNAs (lncRNAs) for competing endogenous RNAs (ceRNAs) network-regulated palatal shelf fusion in the development of mouse cleft palate.

Authors:  Xuan Shu; Zejun Dong; Mingjun Zhang; Shenyou Shu
Journal:  Ann Transl Med       Date:  2019-12

10.  Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors.

Authors:  P K Manchanda; G N Jones; A A Lee; D R Pringle; M Zhang; L Yu; K M D La Perle; L S Kirschner
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.